ArticleCureus2026
Radiotherapy for Refractory Cystic Progression in Basal Ganglia Pilocytic Astrocytoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pilocytic astrocytoma (PA) is a common low-grade pediatric glioma that often exhibits cystic components. Although cyst-related symptoms are usually controlled by gross-total resection or cerebrospinal fluid (CSF) diversion procedures, management can be challenging when tumors arise in deep or eloquent locations and are associated with highly proteinaceous cyst fluid. We report a case of a 14-year-old girl with PA arising in the basal ganglia who developed recurrent and refractory cystic enlargement following chemotherapy. Despite multiple interventions, including Ommaya reservoir placement, repeated cyst aspirations, endoscopic cyst fenestrations, and cystoperitoneal and ventriculoperitoneal shunts, cyst control was repeatedly compromised due to obstruction associated with extremely high cyst fluid protein levels. Although cyst-ventricle communication resulted in a marked reduction in protein concentration, recurrent obstruction and cyst re-expansion persisted. Given the refractory nature of the cystic lesion and the absence of endocrine dysfunction, fractionated radiotherapy was selected. Following radiotherapy (60 Gy in 30 fractions), magnetic resonance imaging revealed reduced contrast enhancement and stabilization of the cystic component. The patient remained clinically stable without treatment-related adverse events or cyst enlargement during the two-year follow-up. This case highlights the limitations of conventional surgical and CSF diversion strategies for cystic PA with high proteinaceous content. Radiotherapy may be a viable therapeutic option for refractory cystic progression in patients with PA, even in the absence of solid tumor growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.